National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting February 10-11, 2015. The meeting is open to the public. However, pre-registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac. Participants may also register by emailing firstname.lastname@example.org or by calling 202-690-5566 to provide your name, organization, and email address.
The meeting will be held on February 10-11, 2015. The meeting times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac as soon they become available.
U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, DC 20201.Start Printed Page 2108
The meeting can also be accessed through a live webcast the day of the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715-H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: email@example.com.
End Further Info
Start Supplemental Information
Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program's responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program.
The topics planned for the February NVAC meeting will include a number of sessions addressing vaccine innovation. The NVAC will hear about current U.S. government-wide strategies to combat antimicrobial resistance followed by a panel discussion on the role vaccines (both existing and new) could play in those strategies. The Institute of Medicine will present their recently released report on the Strategic Multi-Attribute Ranking Tool for Vaccines (SMART-Vaccines) software developed to support prioritization of new vaccine research and development. NVAC will then hear from beta-testers of the SMART-Vaccine software about their experience and possible uses for the tool going forward. NVAC will also discuss the on-going efforts to better understand and overcome the barriers to sharing immunization registry data between states.
NVAC will preview both the National Vaccine Annual Report and the National Adult Immunization Plan. In addition, the Vaccine Confidence/Acceptance and the NVAC HPV working groups will present their draft report and draft recommendations for NVAC consideration and discussion. Finally, the NVAC Maternal Immunization and the NVAC Mid-Course Review Working Groups will provide an update on their progress. The meeting agenda will be posted on the NVAC Web site: http://www.hhs.gov/nvpo/nvac prior to the meeting.
Public attendance at the meeting is limited to the available space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.
Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Individuals who would like to submit written statements should email their comments to the National Vaccine Program Office (firstname.lastname@example.org) at least five business days prior to the meeting.
End Supplemental Information
Dated: 12 January 2015.
Executive Secretary, National Vaccine Advisory Committee, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office.
[FR Doc. 2015-00519 Filed 1-14-15; 8:45 am]
BILLING CODE 4150-44-P